SOPHiA GENETICS SA SOPH 深 滬
已收盤 04-02 16:00:00 美东时间
5.04
-0.050
-0.98%
華盛通- 最 高5.24
- 今 開5.05
- 成交量 8.34万股
- 最 低 4.92
- 昨 收 5.09
- 總市值 3.61亿
- 52周最高 5.70
- 市盈率 靜 --
- 換手率 0.12%
- 52周最低 2.58
- 委 比 -99.39%
- 總股本 7166.87万
- 歷史最高 19.80
- 量 比 1.24
- 振 幅 6.29%
- 歷史最低 1.685
- 每 手 1
- 風險率 0.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SOPHiA GENETICS shares are trading lower after the company reported worse-than-expected Q4 EPS results.
SOPHiA GENETICS shares are trading lower after the company reported worse-than-...
03-04 04:35
Sophia Genetics Q4 Earnings Summary & Key Takeaways
Sophia Genetics (NASDAQ:SOPH) reported its Q4 earnings results on Tuesday, Marc...
03-03 19:50
Sophia Genetics Sees FY2026 Sales $92.000M-$94.000M vs $88.000M Est
2026 Financial OutlookBased on information as of today, SOPHiA GENETICS is reaffirming the following guidance:Full-year revenue between $92 million and $94 million, representing approximately 20% to 22% year-over-year
03-03 19:47
Earnings Scheduled For March 3, 2026
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is expected to rep...
03-03 19:11
A Look at Sophia Genetics's Upcoming Earnings Report
Sophia Genetics (NASDAQ:SOPH) is preparing to release its quarterly earnings on...
03-03 02:01
SOPHiA GENETICS Adds Two U.S. Healthcare Systems To Its Network To Leverage AI-Native, Cloud-Based SOPHiA DDM To Analyze Complex Genomic Data At Scale
SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced the addition of two of the largest U.S. healthcare systems to its network.The two new institutions, which collectively
02-10 22:27
SOPHiA GENETICS Secures Additional $25 Million Term Loan Commitments from Perceptive Credit Holdings
SOPHiA GENETICS Secures Additional $25 Million Term Loan Commitments from Perceptive Credit Holdings SOPHiA GENETICS SA has announced an amendment to its existing credit agreement with Perceptive Credit Holdings IV, LP, originally dated May 2, 2024. The Second Amendment, entered into on January 23,
01-29 05:10
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
Guggenheim Maintains Buy on Sophia Genetics, Raises Price Target to $7
Guggenheim analyst Subbu Nambi maintains Sophia Genetics (NASDAQ:SOPH) with a Buy and raises the price target from $6 to $7.
01-27 00:39
SOPHiA GENETICS Promotes Ross Muken To CEO, Effective July 2026, As Co‑Founder Jurgi Camblong Moves To Executive Chairman Role
Executive Transition PlanSOPHiA GENETICS today announced the promotion of Ross Muken to Chief Executive Officer, effective July 1, 2026. Mr. Muken, who currently serves as President and has been a key executive at the
01-12 20:07
